Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Fresenius Medical Care North America Presents New Insights for Kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week

November 6, 2019 GMT
(PRNewsfoto/Fresenius Medical Care North Am)
(PRNewsfoto/Fresenius Medical Care North Am)

WALTHAM, Mass., Nov. 6, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, today announced the presentation or publication of 87 affiliated abstracts at the 2019 American Society of Nephrology’s (ASN) Kidney Week in Washington D.C. from Nov. 7-10, 2019. The quality improvement and research efforts reflect work from every part of the company and include eight oral presentations.

The company’s clinical experts will reveal multiple insights and methods to advance kidney care, including new data and research around acute kidney injury (AKI), home dialysis, artificial intelligence, a novel dialyzer, and new tools for vascular care.

“Our research continues to demonstrate our commitment to improving care for patients with kidney disease by identifying new insights and real solutions,” said Dr. Robert Kossmann, Chief Medical Officer for FMCNA. “This year, we’re particularly pleased to highlight new data that adds to the limited information on different patterns of renal recovery for patients with AKI that may help identify additional therapeutic interventions for these patients.”

The annual symposium is the most influential gathering of kidney professionals in the world, drawing more than 13,000 physicians, scientists, and healthcare professionals from over 100 countries.

Highlights of key Fresenius Medical Care presentations at the 2019 ASN Kidney Week include:

To learn more about the research presented at Kidney Week and advancements in dialysis care presented by FMCNA, please visit us at www.fmcna.com/asn2019.

About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com.

Media Contact:

Fresenius Medical Care North America
Brad Puffer
Corporate Communications
(781) 699-3331

View original content to download multimedia: http://www.prnewswire.com/news-releases/fresenius-medical-care-north-america-presents-new-insights-for-kidney-care-at-the-american-society-of-nephrology-asn-annual-kidney-week-300952161.html

SOURCE Fresenius Medical Care Holdings, Inc.